Experience with non-cremophor-based paclitaxel-gemcitabine regimen in advanced pancreatic cancer: Results from a single tertiary cancer centre

BACKGROUND & OBJECTIVES: Gemcitabine combined with non-cremophor-based paclitaxel is one of the standards of care in advanced inoperable pancreatic cancer. This study was undertaken to retrospectively evaluate real world non-trial outcomes with this combination. METHODS: Patients with histologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostwal, Vikas, Sahu, Arvind, Zanwar, Saurabh, Nayak, Lingaraj, Shrikhande, Shailesh V., Shetty, Nitin, Gupta, Sudeep, Ramaswamy, Anant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251278/
https://www.ncbi.nlm.nih.gov/pubmed/30425218
http://dx.doi.org/10.4103/ijmr.IJMR_249_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251278/
https://www.ncbi.nlm.nih.gov/pubmed/30425218
http://dx.doi.org/10.4103/ijmr.IJMR_249_17

Ejemplares similares